Moreover, all patients with SCAD were on statin treatment, which reduces the levels of NT-proBNP after a cardiovascular event such as acute myocardial infarction [22], and in patients with dilated cardiomyopathy [23] or heart failure [24]. This evidence concerns the gene NPPB and myocardial infarction.